Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01136798 · ClinicalTrials.gov registry record · NA

Impact of Exenatide on Sleep in Type 2 Diabetes

A NA study of Type 2 Diabetes and Sleep Disordered Breathing, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
18
Enrollment target
2
Study locations

NCT01136798 is a NA study of Type 2 Diabetes and Sleep Disordered Breathing that has completed, run by University of Chicago. The registered enrollment target is 18 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01136798, a NA study of Type 2 Diabetes and Sleep Disordered Breathing, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
2
Study locations

Study Summary

The investigators propose a pilot study to test the novel hypothesis that Exenatide treatment in patients with type 2 diabetes results in improved sleep duration and quality and to explore the relationship between improvements in sleep and measures of metabolic and circadian function. This project would be the first to probe the relationship between incretin hormone regulation, duration and intensity of sleep, glucose tolerance and circadian dysfunction in diabetic patients.

Conditions Studied

Type 2 Diabetes Sleep Disordered Breathing

Interventions

  • DRUG Placebo
  • DRUG Exenatide

Study Locations (2)

Illinois

  • The University of Chicago - Chicago
  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2010-06-01
Est. Completion 2016-09-01
Phase NA

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01136798

The ClinicalTrials.gov registry entry for NCT01136798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01136798 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01136798 about?

NCT01136798 is a clinical study titled "Impact of Exenatide on Sleep in Type 2 Diabetes". The investigators propose a pilot study to test the novel hypothesis that Exenatide treatment in patients with type 2 diabetes results in improved sleep duration and quality and to explore the relationship between improvements in sleep and measures of metabolic and circadian function. This project w...

What is the current status of trial NCT01136798?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2010-06-01. Estimated completion is 2016-09-01.

What conditions does trial NCT01136798 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Sleep Disordered Breathing.

What interventions are being tested in trial NCT01136798?

The interventions under investigation include: Placebo (DRUG), Exenatide (DRUG).

Who is sponsoring clinical trial NCT01136798?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01136798 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

Sleep Disordered Breathing

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.